KAI and Sankyo Enter Global Alliance in Cardiovascular Disease |
Abstract
pdf
|
Business Review Editor |
|
Wyeth's Recognition of the Worth of Biotech |
Abstract
pdf
|
Business Review Editor |
|
Nuvelo: the Vindication of a Merger |
Abstract
pdf
|
Business Review Editor |
|
Deal Making in the New Healthcare Landscape |
Abstract
pdf
|
Business Review Editor |
|
Therapy Focus: Antiplatelet Therapy |
Abstract
pdf
|
Business Review Editor |
|
Pfizer Secures Rights to Exubera® from Sanofi-Aventis |
Abstract
pdf
|
Business Review Editor |
|
Amarin and Multicell Sign Exclusive Licence Agreement for MS Fatigue Treatment |
Abstract
pdf
|
Business Review Editor |
|
AstraZeneca’s Christmas Shopping Spree |
Abstract
|
Business Review Editor |
|
What's Special About Speciality? |
Abstract
html
|
Fintan Walton |
|
J&J’s Takeover of Guidant Terminated |
Abstract
pdf
|
Business Review Editor |
|
Amgen to Acquire Abgenix for US$2.2 B |
Abstract
pdf
|
Business Review Editor |
|